Trials / Terminated
TerminatedNCT03107806
Monitoring Glucose Levels in Patients With Myocardial Infarction
COMGAMI Continuous Monitoring of Glucose in Acute Myocardial Infarction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Lars Ryden · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes
Detailed description
Methodology Part a) Explorative Part b) Randomised, parallel-group design
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OptiScanner® | 1. Glucose monitoring by OptiScanner® for 48 h 2. Glucose lowering intervention (insulin) guided by OptiScanner® |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2017-04-11
- Last updated
- 2019-08-15
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03107806. Inclusion in this directory is not an endorsement.